The National Cancer Institute and guideline development: lessons from the breast cancer screening controversy.
Kaluzny
A D
AD
University of North Carolina, Chapel Hill 27599-7590.
Rimer
B
B
Harris
R
R
D000328:Adult; D026683:Advisory Committees; D000367:Age Factors; D000368:Aged; D001943:Breast Neoplasms / Q000175:diagnosis*; D003362:Cost-Benefit Analysis; D005260:Female; D017408:Guidelines as Topic; D006801:Humans; D033183:Interdisciplinary Communication; D038622:Internationality; D008327:Mammography; D008403:Mass Screening; D008875:Middle Aged; D009316:National Institutes of Health (U.S.) / Q000592:standards*; D018570:Risk Assessment; D036302:Therapeutic Human Experimentation; D014481:United States